<bill session="109" type="h" number="1669" updated="2019-11-15T21:18:35Z">
  <state datetime="2005-04-14">REFERRED</state>
  <status>
    <introduced datetime="2005-04-14"/>
  </status>
  <introduced datetime="2005-04-14"/>
  <titles>
    <title type="short" as="introduced">Pharmacy Benefit Manager Transparency Act of 2005</title>
    <title type="display">Pharmacy Benefit Manager Transparency Act of 2005</title>
    <title type="official" as="introduced">To ensure integrity in the operation of pharmacy benefit managers.</title>
  </titles>
  <sponsor bioguide_id="W000792"/>
  <cosponsors>
    <cosponsor bioguide_id="B001236" joined="2005-12-08"/>
    <cosponsor bioguide_id="M000934" joined="2005-04-14"/>
  </cosponsors>
  <actions>
    <action datetime="2005-04-14">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-04-14" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2005-05-13">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Law"/>
    <term name="Business records"/>
    <term name="Commerce"/>
    <term name="Consumer discounts"/>
    <term name="Consumer education"/>
    <term name="Consumer protection"/>
    <term name="Contracts"/>
    <term name="Drug industry"/>
    <term name="Drug utilization"/>
    <term name="Drugs"/>
    <term name="Fees"/>
    <term name="Finance and Financial Sector"/>
    <term name="Financial statements"/>
    <term name="Fines (Penalties)"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Health"/>
    <term name="Health care fraud"/>
    <term name="Health insurance"/>
    <term name="Insurance companies"/>
    <term name="Medical statistics"/>
    <term name="Patients' rights"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Restrictive trade practices"/>
  </subjects>
  <amendments/>
  <summary date="2005-05-23T21:43:45Z" status="Introduced in House">Pharmacy Benefit Manager Transparency Act of 2005 - Prohibits any pharmaceutical drug manufacturer from having a controlling interest in an entity that is a pharmacy benefit manager. Allows the Secretary of Health and Human Services to issue civil penalties for violations as necessary.

Prohibits pharmacy benefit managers from making drug interchanges: (1) to a drug with a greater cost; (2) without disclosure to the individual of the savings associated with the interchange; or (3) from a drug with generic equivalents to a drug without generic equivalents, unless the latter is lower in cost than each of the generic equivalents of the drug from which the prescription would be changed.

Requires pharmacy benefit managers to annually disclose all compensation received from drug manufacturers to the Antitrust Division of the Department of Justice (DOJ) and to the client plans of such manager.</summary>
</bill>
